Referral pathways and management of contact lens-related microbial keratitis in Australia and New Zealand

Clinical and Experimental Ophthalmology

Volumn 36, Issue 3, 2008, Pages 209-216

  Keay, Lisa ^a,b,c,d   Edwards, Katie ^a   Stapleton, Fiona ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Contact lens related microbial keratitis; Health care; Referral; Treatment

Indexed keywords

ACICLOVIR; AMINOGLYCOSIDE; BIGUANIDE DERIVATIVE; CEFALOTIN; CEPHALOSPORIN; CHLORAMPHENICOL; CHLORHEXIDINE; CIPROFLOXACIN; CODEINE PHOSPHATE; DEXAMETHASONE; FLUOROMETHOLONE; FUSIDIC ACID; GENTAMICIN; HYDROCORTISONE; IBUPROFEN; NAPHAZOLINE; NATAMYCIN; NEOSPORIN; NUROFEN PLUS; OFLOXACIN; POLYHEXYLMETHYLBIGUANIDE; PREDNISOLONE; PROMETHAZINE; PROPAMIDINE ISETHIONATE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; SULFACETAMIDE; TOBRAMYCIN; UNCLASSIFIED DRUG; VORICONAZOLE;

ACANTHAMOEBA KERATITIS; ADULT; ARTICLE; AUSTRALIA AND NEW ZEALAND; CONSULTATION; CONTACT LENS; DISEASE SEVERITY; DRUG RESPONSE; EMERGENCY WARD; FEMALE; GENERAL PRACTITIONER; HOSPITAL ADMISSION; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; KERATITIS; KERATOMYCOSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OPTOMETRY; OUTPATIENT CARE; PATIENT REFERRAL; PRIVATE HOSPITAL; PROSTHESIS INFECTION; THERAPY DELAY;

ADOLESCENT; ADULT; AMBULATORY CARE; AUSTRALIA; CONTACT LENSES; EMERGENCY MEDICAL SERVICES; FAMILY PRACTICE; HEALTH SERVICES ACCESSIBILITY; HOSPITALIZATION; HUMANS; KERATITIS; MIDDLE AGED; NEW ZEALAND; OPTOMETRY; PILOT PROJECTS; REFERRAL AND CONSULTATION; TIME FACTORS;

EID: 42449126107     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2008.01722.x     Document Type: Article

References (23)

1. Poggio E, Glynn R, Schein OD et al. The incidence of ulcerative keratitis among users of daily-wear and extended-wear soft contact lenses. N Eng J Med 1989; 321: 779-83.
2. Cheng K, Leung S, Hoekman H et al. Incidence of contact-lens-associated microbial keratitis and its related morbidity. Lancet 1999; 354: 181-5.
3. Lam DS, Houang E, Fan DS, Lyon D, Seal D, Wong E, Hong Kong Microbial Keratitis Study Group. Incidence and risk factors for microbial keratitis in Hong Kong: Comparison with Europe and North America. Eye 2002; 16: 608-18.
4. Seal DV, Kirkness CM, Bennett HGB, Peterson M, Keratitis Study Group. Population-based cohort study of microbial keratitis in Scotland: incidence and features. CL Ant Eye 1999; 22: 49-57.
5. Keay L, Edwards K, Naduvilath T et al. Microbial keratitis: Predisposing factors and morbidity. Ophthalmol 2006; 113: 109-16.
6. Keay L, Edwards K, Brian G, Stapleton F. Surveillance of contact lens-related microbial keratitis in Australia and New Zealand: multi-source case-capture and cost-effectiveness. Ophthalmic Epidemiol 2007; 14: 343-50.
7. Stapleton F, Keay L, Edwards K et al. The incidence of contact lens related microbial keratitis in Australia. Ophthalmology 2008 (In press).
8. Keay LEK, Naduvilath T, Forde K, Stapleton F. Factors affecting the morbidity of contact lens-related microbial keratitis: A population study. Invest Ophthalmol Vis Sci 2006; 47: 4302-8.
9. Miedziak AI, Miller MR, Rapuano CJ, Laibson PR, Cohen EJ. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology 1999; 106: 1166-70.
10. Gebauer A, McGhee CN, Crawford GJ. Severe microbial keratitis in temperate and tropical Western Australia. Eye 1996; 10: 575-80.
11. Keay L, Edwards K, Naduvilath T, Forde K, Stapleton F. Factors affecting the morbidity of contact lens-related microbial keratitis: A population study. Invest Ophthalmol Vis Sci 2006; 47: 4302-8.
12. Keay L, Edwards K, Brian G, Naduvilath T, Stapleton F. Evaluation of surveillance methods for an epidemiological study of contact lens related microbial keratitis. Clin Exp Ophthalmol 2004; 32: 349-53.
13. Keay L, Edwards K, Dart JK, Stapleton F. Grading of CL-related microbial keratitis: Relevance to disease burden. Optom Vis Sci 2008 (In press).
14. Wilhelmus KR, Schlech BA. Clinical and epidemological advantages of culturing bacterial keratitis. Cornea 2004; 23: 38-42.
15. Eckert KA, Taylor AW, Wilkinson D. Does health service utilisation vary by remoteness? South Australian population data and the Accessibility and Remoteness Index of Australia. Aust N Z J Public Health 2004; 28: 426-32.
16. McDonnell PJ, Nobe J, Gauderman WJ, Lee P, Aiello A, Trousdale M. Community care of corneal ulcers. [see comment]. Am J Ophthalmol 1992; 114: 531-8.
17. McAllum P, McGhee C. Prescribing trends in infectious keratitis: A survey of New Zealand ophthalmologists. Clin Exp Ophthalmol 2003; 31: 496-504.
18. McDonnell PJ. Empirical or culture-guided therapy for microbial keratitis? A plea for data. Arch Ophthalmol 1996; 114: 84-7.
19. Britt H, Miller G, Charles J et al. General practice activity in Australia 2005-06. Gen Pract Ser 2007; No. 19. AIHW cat. no. GEP 19.
20. Mills R. Microbial keratitis: What's the preferred initial therapy? View 1: Corneal scraping and combination antibiotic therapy is indicated. [see comment]. Br J Ophthalmol 2003; 87: 1167-9.
21. Morlet N, Daniell M. Microbial keratitis: What's the preferred initial therapy? View 2: Empirical fluoroquinolone therapy is sufficient initial treatment. [see comment]. Br J Ophthalmol 2003; 87: 1169-72.
22. Stapleton F, Keay L, Sanfilippo P, Katiyar S, Edwards K, Naduvilath T. Relationship between climate, disease severity and causative organism for contact lens associated microbial keratitis in Australia. Am J Ophthalmol 2007; 144: 690-8.
23. McGhee CN, Dean S, Danesh-Meyer H. Locally administered ocular corticosteroids: Benefits and risks. Drug Saf 2002; 25: 33-55.